SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma informs about board meeting

08 May 2025 Evaluate
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and other regulations, if applicable, Marksans Pharma has informed that a meeting of the Board of Directors of the Company will be held on Monday, May 19, 2025 at Mumbai, to transact the following businesses: 1. To consider and approve the Audited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and Year ended March 31, 2025. 2. To consider recommendation of dividend on the equity shares for the financial year 2024- 25, if any. As per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Company’s Internal Code on Prohibition of Insider Trading, the Trading Window for dealing in Company’s shares has been closed for the Company’s Designated Persons (including Directors) and their immediate relatives from April 01, 2025 and will remain closed till Forty-Eight hours after the announcement of the Financial Results i.e. up to May 21, 2025. Further, as per the Listing Regulations, this intimation of the Board Meeting would be available on the website of the Company: www.marksanspharma.com, BSE: www.bseindia.com and National Stock Exchange of India: www.nseindia.com. 

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

203.20 5.30 (2.68%)
11-May-2026 15:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×